Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bayer
City of Hope Medical Center
Novartis
Novartis
NeoTX Therapeutics Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Valo Therapeutics Oy
Cancer Research UK
Theratechnologies
University Health Network, Toronto
Salubris Biotherapeutics Inc